Growth ConcernsThere are concerns over weaker growth in Cemex's main markets, Mexico and the US, and the contribution of growth capital expenditures not resulting in double-digit growth.
Market ChallengesCemex will face another challenging quarter with soft results from the US and weakness from Mexico, partly offset by a solid performance from Europe.
Valuation ConcernsCX is trading at 6.3x forward EBITDA, which is 10% above the 5-year average, indicating potential overvaluation.